NCT02448381 · Interventional trial
FLASH [Fluorescent Light Activated Synthetic Hypericin] Clinical Study: Topical SGX301 (Synthetic Hypericin) for the Treatment of Cutaneous T-Cell Lymphoma (Mycosis Fungoides)
Overall registry status Completed
Phase 3
Conditions Cutaneous T-Cell Lymphoma
Delaware Valley sites
- Hospital of the University of Pennsylvania · Philadelphia, PA · Philadelphia County
- Jefferson Dermatology · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory